Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
12/2010
12/08/2010CN101909619A Composition comprising sesamin component and quercetin glycoside
12/08/2010CN101906107A Method for synthesizing camphoricanhydride by alpha-pinene
12/08/2010CN101412725B Method for extracting and separating bilobalide B from ginkgo leaf
12/08/2010CN101412722B Method for extracting and separating bilobalide C from ginkgo leaf
12/08/2010CN101074234B Antitumor antibiotics and its production
12/07/2010USRE41990 epothilone derivatives used for the treatment of cancer and cancers which have developed a multidrug-resistant phenotype; anticarcinogenic agents
12/07/2010US7847109 Triptolide derivatives for modulation of apoptosis and immunosuppression
12/07/2010US7846952 epothilone derivatives in combination with carriers or diluents, used for plant protection in agriculture, forestry or horticulture; plant safening agents
12/07/2010US7846926 podophyllotoxin derivatives such as (2-{3-[4-(3-aminopropylamino)-butylamino]-propylamino}-N-[9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5,6,8,8a,9-hexahydrofuro[3',4':6,7]naptho[2,3-d][1,3]dioxol-5-yl]-acetamide, used as anticarcinogenic agents
12/07/2010US7846890 3-acetate of [1aR-(1a alpha ,2 beta ,3 beta ,4a beta ,8aS)]-decahydro-2,4a,8,8-tetramethyl-cyclopropa[d]naphthalene-2,3-diol; 2,3-(dimethylmethylenedioxy)-1,8a-methano-2,4a,8,8-tetramethyldecahydronaphthalene; detergent, fabric softener, perfume, cologne, perfumed soap, paper, wipe, bleach etc.
12/07/2010US7846422 Administering a lignan comprising 4-(phenyl)-furo/3*,4*:6,7/-naphtho/2,3-d/-1,3-dioxole derivative or plant extract
12/07/2010CA2374995C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
12/02/2010WO2010137285A1 Anthracene derivative and organic electroluminescent element using the same
12/02/2010WO2010136431A1 Spiro epoxides as intermediates
12/02/2010US20100305173 Hydroxyethylamino sulfonamide derivatives
12/02/2010CA2763830A1 Novel compounds
12/01/2010EP2254898A2 Method for preparation of anhydrosugar ethers
12/01/2010EP2254891A2 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers
12/01/2010CN101903393A Novel herbicides
12/01/2010CN101902916A Novel systemic pesticide
12/01/2010CN101899055A Method for rapidly extracting artemisinin
12/01/2010CN101899054A Antiatherosclerotic sparstolenin B compound and preparation method thereof
12/01/2010CN101899053A C crystal form solid matter of bergenin and preparation method and application thereof
12/01/2010CN101899052A B-crystal form solid matter of bergenin and preparation method and application thereof
12/01/2010CN101337968B Carboxylic acid rotenonoxime ester, method for preparing same and applications
11/2010
11/30/2010US7842822 (3aS, 4S, 9bS)-4-(4-Hydroxy-phenyl)-1,3a,4,9b-tetrahydro-3H-2,5-dioxa-cyclopenta[a]naphthalen-8-ol, used for the treatment of benign prostatic hyperplasia, cardiovascular diseases, neurodegenerative disorders, incontinence, nervous system disorders, gastrointestinal disorders and osteoporosis
11/30/2010US7842687 Cephalotaxane derivatives and their processes of preparation and purification
11/30/2010CA2335477C Sulfonamide inhibitors of aspartyl protease
11/25/2010WO2010135427A2 Trioxane monomers and dimers
11/25/2010WO2010080415A3 Substituted afpo (6-aryl-4h-furo[3,2-c]pyran-4-one) derivatives as anti-cancer agents
11/25/2010US20100298422 Novel polyspirane compounds, application thereof in the treatment of malaria or toxoplasmosis and method for preparing same
11/25/2010US20100298140 Novel herbicides
11/25/2010DE102009039801A1 Polymerisierbare chirale Verbindungen Polymerizable chiral compounds
11/24/2010EP2253639A1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues
11/24/2010EP2253636A1 Neuronal cell death inhibitor
11/24/2010CN101896491A Fluorescent molecule
11/24/2010CN101891752A Prodrug of DCK (deoxycytidine kinase) analogue, preparation method and application thereof
11/24/2010CN101318965B Hairy sepal ponicidin crystallization, preparation method and medicament composition containing the same
11/24/2010CN101306613B Color imaging method
11/24/2010CN101074233B 4'-demethylpodoph-yllotoxin derivative, its production and use
11/23/2010CA2411741C Method for purifying a composition containing at least an internal dehydration product for a hydrogenated sugar
11/18/2010WO2010132599A1 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
11/18/2010WO2010132538A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases
11/18/2010WO2010131566A1 Tetracarboxylic acid dianhydride and polymer
11/18/2010WO2010130840A1 Triazole/tetrazole polymers resulting from the cycloaddition of functionalized monomers derived from dianhydrohexitol, intermediate compounds, methods of preparing same and applications thereof
11/18/2010WO2010067078A3 3,6-disubstituted xanthylium salts as medicaments
11/18/2010WO2010059611A3 Inhibitors of diacylglycerol acyltransferase
11/18/2010WO2010032165A3 Prodrugs of artemisinin
11/18/2010CA2761881A1 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
11/18/2010CA2760205A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases
11/17/2010EP2250177A1 Luminescence quenchers and fluorogenic probes for detection of reactive species
11/17/2010CN101889009A Inhibitors of c-fms kinase
11/17/2010CN101889006A Intermediates and methods for making zearalenone macrolide analogs
11/17/2010CN101889005A Intermediates in the synthesis of zearalenone macrolide analogs
11/17/2010CN101885729A Method for preparing liquid product enriched in isosorbide by cracking kelp
11/16/2010US7834043 Prevent reproduct of aids virus
11/11/2010WO2010129379A1 Inhibitors of the renal outer medullary potassium channel
11/11/2010US20100286393 Increasing the In Vivo Biological Activity of Biologically Active Compounds
11/11/2010US20100286123 Inhibitors of the renal outer medullary potassium channel
11/11/2010US20100285141 Compositions and methods for enhancing the activity of podophyllotoxin
11/11/2010US20100284925 Small Molecule Intervention for Obesity
11/11/2010CA2759399A1 Inhibitors of the renal outer medullary potassium channel
11/10/2010EP2247586A1 2-aza-bicyclo[2.2.1]heptane derivatives
11/10/2010CN101883773A Polyketal compounds, synthesis, and applications
11/10/2010CN101883763A Intermediates and methods for the synthesis of halichondrin b analogs
11/10/2010CN101880286A Water-soluble amino-acid ester derivative of ginkgolide B
11/10/2010CN101318946B Dimeric ainsliaea terpene A, preparation and application thereof
11/04/2010WO2010080414A3 Substituted fno (2-[furan-2-yl] naphthalen-1-ol) derivatives as anti-cancer agents
11/04/2010US20100280263 Process for the Synthesis of Anticancer (Poly) Aminoalkylaminoacetamide Derivatives of Epipodophyllotoxin
11/04/2010US20100280262 Bryostatin analogues, synthetic methods and uses
11/04/2010US20100280091 Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disbustituted pyran derivatives
11/03/2010EP2246418A1 Lignan hydroxylase
11/03/2010EP2244999A1 Antimicrobial surfaces
11/03/2010EP2244571A1 Small molecule inhibitors of hiv proteases
11/03/2010CN101875945A Avermectin aglycon synthase genes
11/03/2010CN101235039B Chemical total synthesis method for wedelolactone
11/03/2010CN101230068B Application of polyether triterpene compound in preparing medicine for treating tumour
11/03/2010CN101130548B Method for extracting and producing high content arteannuin
11/02/2010USRE41911 Epothilone derivatives
11/02/2010US7825147 Enzyme inhibitors of phosphodiesterases for treatment of AIDS, asthma, arthritis, bronchitis and other disorders
11/02/2010US7825141 Epothilone derivatives
11/02/2010US7825094 the sensitivity of cells typical of various proliferative disorders to the ansamycin CNF-101 ("17-AAG") is proportional to the HER-2 levels in those cells
10/2010
10/28/2010WO2010122436A1 Rifamycin derivatives
10/28/2010US20100274030 Cyclic ethers
10/28/2010US20100273830 Novel insecticides
10/28/2010CA2743801A1 Rifamycin derivatives
10/27/2010EP2242502A1 Synthesis of macrocyclic cancer chemotherapy agents and methods of use
10/27/2010CN101870702A Preparation method of methoxsalen
10/27/2010CN101870701A Bergenin isopentene group derivative and preparation method and application thereof
10/26/2010USRE41895 Epothilone derivatives
10/26/2010USRE41893 Epothilone derivatives
10/26/2010US7820839 Taxoid-fatty acid conjugates and pharmaceutical compositions thereof
10/26/2010US7820838 Ecteinascidin 743; 5-(1,2-diaminoethyl-), 3,4-methylenedioxyphenol intermediate, of which the amine group cyclizes
10/26/2010US7820834 Triptolide 5,6-derivatives as immunomodulators and anticancer agents
10/26/2010US7820616 such as 1,4-diethyl-6,8-dioxa-bicyclo[3.2.1]octane; also for use in cologne, toilet water, cosmetics, personal care products, fabric care products, cleaning products (detergents, window cleaners, dishwashing, scrubbing), and air fresheners
10/26/2010CA2293436C Imidazolyl-cyclic acetals as tnf inhibitors
10/21/2010WO2010119890A1 Method for producing tetrahydropyran compound and intermediate thereof
10/21/2010US20100267964 N-heterocyclylphenyl-substituted cyclic ketoenols
10/21/2010US20100267609 Compounds which inhibit beta-secretase activity and methods of use thereof
10/21/2010US20100266570 Dimeric derivatives of artemisinin and application in anticancer therapy
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 174